Hayfever alert: bad allergy season ahead
An international group of experts have pooled resources to map out treatment options for patients with allergic rhinitis (AR) and chronic rhinosinusitis (CRS) who experience poor control of symptoms despite guideline-directed pharmacotherapy.
They concluded that AR and CRS diagnosis should be reconsidered in case of uncontrolled disease, excluding concomitant anatomic nasal deformities, global airway dysfunction and systemic diseases. However patient medication adherence was also an issue.
One in six Australians will suffer from hayfever this spring, said